| PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance V Verma, RK Shrimali, S Ahmad, W Dai, H Wang, S Lu, R Nandre, P Gaur, ... Nature immunology 20 (9), 1231-1243, 2019 | 284 | 2019 |
| Rational design of anti-GITR-based combination immunotherapy R Zappasodi, C Sirard, Y Li, S Budhu, M Abu-Akeel, C Liu, X Yang, ... Nature medicine 25 (5), 759-766, 2019 | 229 | 2019 |
| Limited extent and consequences of pancreatic SARS-CoV-2 infection V van der Heide, S Jangra, P Cohen, R Rathnasinghe, S Aslam, T Aydillo, ... Cell reports 38 (11), 2022 | 57 | 2022 |
| Spectral-domain optical coherence tomography enhanced depth imaging of the normal and glaucomatous nonhuman primate optic nerve head H Yang, J Qi, C Hardin, SK Gardiner, NG Strouthidis, B Fortune, ... Investigative ophthalmology & visual science 53 (1), 394-405, 2012 | 45 | 2012 |
| Phase IB study of GITR agonist antibody TRX518 singly and in combination with gemcitabine, pembrolizumab, or nivolumab in patients with advanced solid tumors D Davar, R Zappasodi, H Wang, GS Naik, T Sato, T Bauer, D Bajor, ... Clinical Cancer Research 28 (18), 3990-4002, 2022 | 35 | 2022 |
| Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study A Ozonoff, ND Jayavelu, S Liu, E Melamed, CE Milliren, J Qi, LN Geng, ... Nature communications 15 (1), 216, 2024 | 27 | 2024 |
| A phase II study of panobinostat with lenalidomide and weekly dexamethasone in myeloma A Chari, HJ Cho, S Leng, A Dhadwal, G Morgan, L La, K Garcia, C Carter, ... Blood, The Journal of the American Society of Hematology 126 (23), 4226-4226, 2015 | 26 | 2015 |
| Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients J Diray-Arce, S Fourati, ND Jayavelu, R Patel, C Maguire, AC Chang, ... Cell Reports Medicine 4 (6), 2023 | 25 | 2023 |
| Efficient fluorescence resonance energy transfer in highly stable liposomal nanohybrid cerasome Z Dai, W Tian, X Yue, Z Zheng, J Qi, N Tamai, J Kikuchi Chemical communications, 2032-2034, 2009 | 24 | 2009 |
| Prenatal metal exposures and associations with kidney injury biomarkers in children MD Politis, M Yao, C Gennings, M Tamayo-Ortiz, D Valvi, S Kim-Schulze, ... Toxics 10 (11), 692, 2022 | 14 | 2022 |
| Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer J Anker, SK Pal, S Kim-Schulze, H Wang, R Halperin, A Uzilov, N Imai, ... Journal for immunotherapy of cancer 11 (8), 2023 | 9 | 2023 |
| A molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses PH Comella, E Gonzalez-Kozlova, R Kosoy, AW Charney, IF Peradejordi, ... medRxiv, 2021 | 7 | 2021 |
| Abstract CT018: Intratumor and peripheral Treg modulation as a pharmacodynamic biomarker of the GITR agonist antibody TRX-518 in the first in-human trial R Zappasodi, Y Li, M Abu-Akeel, J Qi, P Wong, C Sirard, M Postow, ... Cancer Research 77 (13_Supplement), CT018-CT018, 2017 | 7 | 2017 |
| Multimodal single-cell characterization of the human granulocyte lineage J Qi, D D’Souza, T Dawson, D Geanon, H Stefanos, R Marvin, L Walker, ... bioRxiv, 2021.06. 12.448210, 2021 | 6 | 2021 |
| Urine supernatant reveals a signature that predicts survival in clear‐cell renal cell carcinoma J Daza, B Salomé, K Okhawere, O Bane, KN Meilika, TG Korn, J Qi, H Xe, ... BJU international 132 (1), 75-83, 2023 | 5 | 2023 |
| Flow cytometry based detection of MRD in bone marrow of patients with multiple myeloma: a comparison between fluorescent-based cytometry versus cytof A Ghosh, N Carreau, A Moscatello, A Rahman, J Qi, S Kim-Schulze, ... Blood 126 (23), 4195, 2015 | 2 | 2015 |
| Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer MD Galsky, H Noah, A Starodub, RJ Hauke, P Twardowski, M Fleming, ... Journal for ImmunoTherapy of Cancer 3, 1-2, 2015 | 2 | 2015 |
| 621 NKG2A and HLA-E define a novel mechanism of resistance to immunotherapy with M. bovis BCG in non-muscle-invasive bladder cancer patients A Horowitz, J Daza, YA Wang, D Ranti, B Salome, E Merritt, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 1 | 2021 |
| Rational combination of GITR agonism with PD-1 blockade R Zappasodi, C Sirard, Y Li, S Budhu, M Abu-Akeel, C Liu, X Yang, ... Cancer Research 79 (13_Supplement), 2711-2711, 2019 | 1 | 2019 |
| Timing of influenza vaccine response in patients that receive autologous hematopoietic cell transplantation KA Sokol, S Kim-Schulze, H Robins, G Obermoser, D Blankenship, J Qi, ... Biology of Blood and Marrow Transplantation 23 (3), S143-S144, 2017 | 1 | 2017 |
